Skip to main content
UCSF ObGyn&RS

Residency Program

About Me

I was born in Valencia, Venezuela and moved to Miami, FL officially in 2002. I spent most of my summer in Venezuela until I was about 16 and still have family over there. I have three sister, two of which have kids. So I have three nieces and nephews and one more nephew on the way! I love my family!

Why OB/GYN?

I went into medical school wanting to pursue a specialty where passionate advocacy was part of the job description and not just an extracurricular activity and when I found OBGYN during my clerkship year, I knew it was the perfect place for me! I am so excited to be advocating for all patients in residency.

Why UCSF?

I was looking for a residency program that matched my personal and professional values and I found exactly that with UCSF. As I was reading the mission statement and the statement of values, it meshed exactly with why I wanted to become a doctor, and an OBGYN, in the first place. Lastly, as a member of the Latinx and LGBTQ+ communities, I was excited to be part of a residency program that celebrated and embraced all of my identities so that I could feel at home.

Outside of Residency

I love anything active from running to dancing to hiking. I began by dancing Salsa and Merengue and over time I’ve picked up other styles. Fun fact, I danced Bhangra for about 4 years in college and a bit in med school!

Roversi, Gustavo
Gustavo Roversi

Resident Physician - PGY 1

[email protected]

If you are a patient, please do not contact a physician by email without their prior expressed consent due to confidentiality concerns.

Main Address

UCSF OB/GYN&RS Residency Program
490 Illinois Street
10th Floor, Box 0132
San Francisco, CA 94143

Location Office Phone Fax
Mission Bay (415) 476 - 5192 (415) 476 - 1811
Mount Zion (415) 353 - 9240 (415) 353 - 9509
San Francisco General Hospital (628) 206 - 3061 (628) 206 - 3112

Research/Clinical Interests: Urogynecology, Pelvic Organ Prolapse Outcomes, Sexual and Gender Minority Health, Chronic Pelvic Pain, Menopause, Medical Education, Minimally Invasive Surgery, Breast and Gynecologic Malignancies

Education/Training

Year

 Institution Degree Field of Study
current University of California, San Francisco Residency Obstetrics, Gynecology and Reproductive Sciences
2019-2024 Cleveland Clinic Lerner College of Medicine MD Medicine
2014-2018 Case Western Reserve University BA Chemistry

Research & Professional Experience

Year  
2022 - 2024 Chronic Pelvic Pain, Pelvic Organ Prolapse Research - Ferrando Lab
2019-2024 Sexual Gender Minority Health - Undergraduate Medical Education Integration
2019 - 2022 Renal Cell Carcinoma Research - Campbell Lab
2015-2019 Research Assistant/Technician - Lathia Lab

Achievements & Recognition
Year Major Honors
2024 Alfred and Normal Lerner Stoller Award for Virtue Based Leadership
2022 AMEF Medical Student Scholarship
2020 CCLCM Alumni Scholarship
2020 Case Med Pride - MSPA Chapter of the Year

Poster Presentations

ROVERSI G, Greene BD, Patterson WM, Lad S, Dean R, Hopkins M, Lambrese V. “An integrated approach to improving medical student LGBTQ+ health knowledge” National LGBTQ Health Conference, Chicago, IL, July 2022.

Naelitz B, ROVERSI G, Munoz-Lopez C, Wood H, Montague D, Angermeier K, Gill B. “Quality of Life Outcomes in Patients Undergoing Artificial Urinary Sphincter Revision Surgery” North Central Section of the AUA Annual Meeting, October 2020.

ROVERSI G, Ducich N, Laura Mintz L, Hopkins M, Lambrese JV. “LGBTQ+ Curricular Needs Assessment: Models, Processes, Reflections” Case Western Reserve University School of Medicine Education Retreat, April 2021

ROVERSI G, Whelan G, Dore S, Ahmadmehrabi S,Yepes-Rios M, Cobb K. “Diversity Dinners at the Cleveland Clinic Lerner College of Medicine” Diversity in Medicine University of Michigan Conference, March 2021.

ROVERSI GA, Silver DJ, Gromosvksy A, Brown JM, Lathia JD. “An Obesity Generating Diet Drives Glioblastoma Progression,” Short Term Research Experience for Underrepresented Persons (STEP-UP) Research Symposium, Bethesda, MD.

Oral Presentations

ROVERSI G, Lambrese JV. “CCLCM LGBTQ+ Curricular Needs Assessment” CCLCM State of the College Address, August 2021.

Publications

Akesson C, Richards EG, Yao M, Ross J, Grima J, May L, ROVERSI G, Ferrando CA. Pelvic Floor Dysfunction Among Persons With Marfan and Loeys-Dietz Syndrome. Urogynecology (Phila). 2024 Mar 18;. PMID: 38517279.

Alban TJ, Grabowski MM, Otvos B, Bayik D, Wang W, Zalavadia A, Makarov V, Troike K, McGraw M, Rabljenovic A, Lauko A, Neumann C, ROVERSI G, Waite KA, Cioffi G, Patil N, Tran TT, McCortney K, Steffens A, Diaz CM, Brown JM, Egan KM, Horbinski CM, Barnholtz-Sloan JS, Rajappa P, Vogelbaum MA, Bucala R, Chan TA, Ahluwalia MS, Lathia JD. The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma. JCI Insight. 2023 Jul 10;8(13). PMID: 37252795; PMCID: PMC10371339.

Lua-Mailland LL, ROVERSI G, Yao M, Ferrando CA. Healthcare Resource Utilization After Apical Prolapse Surgery in Women Who Received In-Office Versus Telephone-Only Preoperative Teaching. Urogynecology (Phila). 2023 Apr 17;. PMID: 37093576.

Rathi N, Attawettayanon W, Yasuda Y, Lewis K, ROVERSI G, Shah S, Wood A, Munoz-Lopez C, Palacios DA, Li J, Abdallah N, Schober JP, Strother M, Kutikov A, Uzzo R, Weight CJ, Eltemamy M, Krishnamurthi V, Abouassaly R, Campbell SC. Point of care parenchymal volume analyses to estimate split renal function and predict functional outcomes after radical nephrectomy. Sci Rep. 2023 Apr 17;13(1):6225. PMID: 37069196; PMCID: PMC10110585.

Mitchell K, Sprowls SA, Arora S, Shakya S, Silver DJ, Goins CM, Wallace L, ROVERSI G, Schafer RE, Kay K, Miller TE, Lauko A, Bassett J, Kashyap A, D'Amato Kass J, Mulkearns-Hubert EE, Johnson S, Alvarado J, Rich JN, Holland EC, Paddison PJ, Patel AP, Stauffer SR, Hubert CG, Lathia JD. WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma. Genes Dev. 2023 Feb 1;37(3-4):86-102. Epub 2023 Feb 2. PMID: 36732025; PMCID: PMC10069451.

Yasuda Y, Zhang JH, Attawettayanon W, Rathi N, Wilkins L, ROVERSI G, Zhang A, Accioly JPE, Shah S, Munoz-Lopez C, Palacios DA, Hofmann M, Campbell RA, Kaouk J, Haber GP, Eltemamy M, Krishnamurthi V, Abouassaly R, Martin C 3rd, Li J, Weight C, Campbell SC. Comprehensive Management of Renal Masses in Solitary Kidneys. Eur Urol Oncol. 2023 Feb;6(1):84-94. Epub 2022 Dec 12. PMID: 36517406.

Michael P, ROVERSI G, Brown K, Sharifi N. Adrenal Steroids and Resistance to Hormonal Blockade of Prostate and Breast Cancer. Endocrinology. 2023 Jan 9;164(3). Review. PMID: 36580423; PMCID: PMC10091490.

Yasuda Y, Zhang JJ, Attawettayanon W, Rathi N, ROVERSI G, Zhang A, Palacios DA, Kaouk J, Haber GP, Krishnamurthi V, Eltemamy M, Abouassaly R, Martin CE, Weight C, Campbell SC. Pathologic Findings and Management of Renal Mass in Horseshoe Kidneys. Urology. 2022 Aug;166:170-176. Epub 2022 Apr 9. PMID: 35405205.

Xiong L, Nguyen JK, Peng Y, Zhou Z, Ning K, Jia N, Nie J, Wen D, Wu Z, ROVERSI G, Palacios DA, Abramczyk E, Munoz-Lopez C, Campbell JA, Cao Y, Li W, Zhang X, He Z, Li X, Huang J, Shou J, Wu J, Chen M, Chen X, Zheng J, Xu C, Zhong W, Li Z, Dong W, Zhao J, Zhang H, Luo J, Liu J, Sun F, Han H, Guo S, Dong P, Zhou F, Yu C, Campbell SC, Zhang Z. What Happens to the Preserved Renal Parenchyma After Clamped Partial Nephrectomy?. Eur Urol. 2022 May;81(5):492-500. Epub 2022 Jan 19. PMID: 35058086.

Silver DJ, ROVERSI GA, Bithi N, Wang SZ, Troike KM, Neumann CK, Ahuja GK, Reizes O, Brown JM, Hine C, Lathia JD. Severe consequences of a high-lipid diet include hydrogen sulfide dysfunction and enhanced aggression in glioblastoma. J Clin Invest. 2021 Jul 13;131(17). doi: 10.1172/JCI138276. PMID: 34255747; PMCID: PMC8409594.

Palacios DA, Zabor EC, Munoz-Lopez C, ROVERSI G, Mahmood F, Abramczyk E, Kelly M, Wilson B, Abouassaly R, Campbell SC. Does Reduced Renal Function Predispose to Cancer-specific Mortality from Renal Cell Carcinoma?. Eur Urol. 2021 Jun;79(6):774-780. Epub 2021 Mar 5. PMID: 33678521.

Bayik D, Lauko AJ, ROVERSI GA, Serbinowski E, Acevedo-Moreno LA, Lanigan C, Orujov M, Lo A, Alban TJ, Kim A, Silver DJ, Nagy LE, Brown JM, Allende DS, Aucejo FN, Lathia JD. Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles. Sci Rep. 2020 Nov 2;10(1):18848. PMID: 33139767; PMCID: PMC7606602.

Bayik D, Zhou Y, Park C, Hong C, Vail D, Silver DJ, Lauko A, ROVERSI G, Watson DC, Lo A, Alban TJ, McGraw M, Sorensen M, Grabowski MM, Otvos B, Vogelbaum MA, Horbinski C, Kristensen BW, Khalil AM, Hwang TH, Ahluwalia MS, Cheng F, Lathia JD. Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner. Cancer Discov. 2020 Aug;10(8):1210-1225. Epub 2020 Apr 16. PMID: 32300059; PMCID: PMC7415660.

Alban TJ, Bayik D, Otvos B, Rabljenovic A, Leng L, Jia-Shiun L, ROVERSI G, Lauko A, Momin AA, Mohammadi AM, Peereboom DM, Ahluwalia MS, Matsuda K, Yun K, Bucala R, Vogelbaum MA, Lathia JD. Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression. Front Immunol. 2020;11:1191. eCollection 2020. PMID: 32625208; PMCID: PMC7315581.

Peereboom DM, Alban TJ, Grabowski MM, Alvarado AG, Otvos B, Bayik D, ROVERSI G, McGraw M, Huang P, Mohammadi AM, Kornblum HI, Radivoyevitch T, Ahluwalia MS, Vogelbaum MA, Lathia JD. Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells. JCI Insight. 2019 Nov 14;4(22). PMID: 31600167; PMCID: PMC6948860.

Jimenez-Pascual A, Hale JS, Kordowski A, Pugh J, Silver DJ, Bayik D, ROVERSI G, Alban TJ, Rao S, Chen R, McIntyre TM, Colombo G, Taraboletti G, Holmberg KO, Forsberg-Nilsson K, Lathia JD, Siebzehnrubl FA. ADAMDEC1 Maintains a Growth Factor Signaling Loop in Cancer Stem Cells. Cancer Discov. 2019 Nov;9(11):1574-1589. 2019 Aug 21. PMID: 31434712; PMCID: PMC7400732.

Advocacy

CCLCM Sexual and Gender Minority Health Curricular Integration Group (2019-2024)